As of 2025-05-17, the Relative Valuation of Vir Biotechnology Inc (VIR) is (70.42) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.60 USD, the upside of Vir Biotechnology Inc based on Relative Valuation is -1630.8%.
The range of the Relative Valuation is (58.83) - (84.54) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.6x - 22.4x | 18.6x |
| Forward P/E multiples | 14.4x - 23.4x | 18.6x |
| Fair Price | (58.83) - (84.54) | (70.42) |
| Upside | -1378.9% - -1937.7% | -1630.8% |
| Date | P/E |
| 2025-05-13 | -1.24 |
| 2025-05-12 | -1.40 |
| 2025-05-09 | -1.34 |
| 2025-05-08 | -1.43 |
| 2025-05-07 | -1.48 |
| 2025-05-06 | -1.49 |
| 2025-05-05 | -1.63 |
| 2025-05-02 | -1.63 |
| 2025-05-01 | -1.61 |
| 2025-04-30 | -1.62 |
| 2025-04-29 | -1.58 |
| 2025-04-28 | -1.61 |
| 2025-04-25 | -1.62 |
| 2025-04-24 | -1.66 |
| 2025-04-23 | -1.58 |
| 2025-04-22 | -1.53 |
| 2025-04-21 | -1.48 |
| 2025-04-17 | -1.45 |
| 2025-04-16 | -1.44 |
| 2025-04-15 | -1.49 |
| 2025-04-14 | -1.47 |
| 2025-04-11 | -1.46 |
| 2025-04-10 | -1.40 |
| 2025-04-09 | -1.51 |
| 2025-04-08 | -1.37 |
| 2025-04-07 | -1.46 |
| 2025-04-04 | -1.48 |
| 2025-04-03 | -1.58 |
| 2025-04-02 | -1.71 |
| 2025-04-01 | -1.63 |
| 2025-03-31 | -1.71 |
| 2025-03-28 | -1.77 |
| 2025-03-27 | -1.76 |
| 2025-03-26 | -1.74 |
| 2025-03-25 | -1.84 |
| 2025-03-24 | -1.90 |
| 2025-03-21 | -1.83 |
| 2025-03-20 | -1.82 |
| 2025-03-19 | -1.84 |
| 2025-03-18 | -1.83 |
| 2025-03-17 | -1.85 |
| 2025-03-14 | -1.89 |
| 2025-03-13 | -1.85 |
| 2025-03-12 | -1.94 |
| 2025-03-11 | -1.94 |
| 2025-03-10 | -1.95 |
| 2025-03-07 | -2.11 |
| 2025-03-06 | -2.13 |
| 2025-03-05 | -2.17 |
| 2025-03-04 | -2.17 |